Found February 23, 2013 on Tito Couture:
PLAYERS: Michael Bisping
Bisping talks his nerve issue, TRT, and why Weidman has no chance at beating Anderson.  Bisping should just start his own TRT, as the saying goes ‘if you can’t beat em, join em!’ Anderson VS Weidman Almost Set For July? Ronda Rousey: “I’m In Fight Mode”
THE BACKYARD
BEST OF MAXIM
RELATED ARTICLES

Bisping Believes Weidman “Does Not Have A Shot” At Beating Silva

British middleweight star Michael Bisping is not one to keep his opinions to himself. The popular fighter has made his views clear about a foray of topics including his dislike for Testosterone Replacement Therapy as well as his opinion on other fighters in his division like Vitor Belfort, Alan Belcher and Chris Weidman.  With news circulating regarding a potential Silva/Weidman...

Ladies Love Michael Bisping

Girls love British accents. Michael Bisping does a staredown with a fan See all fighter video blogs on Intravid.com

Jon Fitch, Michael Bisping, Roy Nelson, and Donald Cerrone: Contenders who could become champions

Close your eyes and go back in the day, back to your freshmen year and you are at the prom/ homecoming/ winter wonderlust – whichever dance the ASB decided to terrorize the school with, and you see the girl of your dreams across the floor. You feel good, looking fresh in a clean Van Heusen button up, maybe even some Dockers to go with it. If you were cool enough, you might even...
All Sports News
Delivered to your inbox
You'll also receive Yardbarker's daily Top 10, featuring the best sports stories from around the web. Customize your newsletter to get articles on your favorite sports and teams. And the best part? It's free!

Today's Best Stuff
For Bloggers

Join the Yardbarker Network for more promotion, traffic, and money.

Company Info
Help
What is Yardbarker?

Yardbarker is the largest network of sports blogs and pro athlete blogs on the web. This site is the hub of the Yardbarker Network, where our editors and algorithms curate the best sports content from our network and beyond.